Antimicrobial resistance in community-acquired urinary tract infections: Results from the Korean Antimicrobial Resistance Monitoring System

Journal of Infection and Chemotherapy

Volumn 17, Issue 3, 2011, Pages 440-446

  Lee, Seung Ju ^d   Lee, Dong Sup ^d   Choe, Hyun Sop ^d   Shim, Bong Suk ^a   Kim, Chul Sung ^b   Kim, Min Eui ^c   Cho, Yong Hyun ^d  

^a Ewha Womans University   (South Korea)

^b Chosun University   (South Korea)

^c Soonchunhyang University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Antimicrobial resistance; Communityacquired infection; Fluoroquinolone; Urinary tract infection

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFAZOLIN; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTITIS; DRUG SURVEILLANCE PROGRAM; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PYELONEPHRITIS; SOUTH KOREA; TREND STUDY; URINARY TRACT INFECTION; URINE CULTURE;

EID: 80051582311     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-010-0178-x     Document Type: Article

References (12)

1. Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents. 2001;4(4):343-8. (Pubitemid 32288753)
2. Kunin C. Urinary tract infections: detection, prevention, and management. 5th ed. Baltimore: Williams & Wilkins; 1997.
3. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin N Am. 1997;11(3):551-81. (Pubitemid 27445472)
4. Lee SJ, Lee SD, Cho IR, Sim BS, Lee JG, Kim CS, et al. Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002. Int J Antimicrob Agents. 2004;24(suppl 1):S61-4. (Pubitemid 39208864)
5. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 8th ed. Approved standard M7-A7. Wayne: CLSI; 2008.
6. Kim ME, Ha US, Cho YH. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006. Int J Antimicrob Agents. 2008;31(suppl 1):S15-8.
7. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008;54:1164-78.
8. Naber KG, Bishop MC, Bjerklund-Johansen TE, et al. The management of urinary and male genital tract infections. In: European Association of Urology, editor. Guidelines edition 2007. ISBN-13:978-90-70244-59-0.
9. Wagenlehner FM, Weidner W, Naber KG. Antibiotics in urology: new essentials. Urol Clin N Am. 2008;1(1):69-79.
10. Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther. 1999;11(11):1864-72.
11. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet. 2001;9271(9271):1851-3. (Pubitemid 32539121)
12. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study. Int J Antimicrob Agents. 2003;22(suppl 2):49-52.